Intrinsiqq
Odyssey Group International Inc. logo

Odyssey Group International Inc. Financials

ODYY

⊜ Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 6 of 14 available years
Income Statement
TTM
JUL 2026
JUL 2025
JUL 2024
JUL 2023
JUL 2022
Revenues
Revenue$0–––––
Cost of Revenue$0–––––
Gross Profit$0–––––
General & Administrative$4$1$1$2$2$3
Research & Development–$0$0$0$0–
Total Operating Expenses$4–––––
Operating Income-$4-$1-$1-$2-$5-$8
Non-Operating
Net Interest Expense-$1-$2-$0-$1-$1-$1
Other Non-Operating Income (Expense)–-$0-$0$0$0–
Income Tax Expense–$0$0$0$0$0
Net Income
Net Income-$4-$6-$2-$1-$6-$8
Per Share Data
Revenue Per Share$0.00–––––
EPS (Basic)-$0.05-$0.05-$0.02-$0.01-$0.07-$0.09
EPS (Diluted)-$0.05-$0.05-$0.02-$0.01-$0.07-$0.09
Weighted Avg Shares (Basic)87.1M108.3M104.7M97.1M82.7M89.0M
Weighted Avg Shares (Diluted)–108.3M104.7M97.1M82.7M89.0M
Shares Outstanding88.6M108.3M104.7M97.1M82.7M89.0M

Odyssey Group International (ODYY) financials: revenue, profit and margins

Odyssey Group International (ODYY) generated about n/a in revenue and -$6 million in net income over the trailing twelve months, growing at roughly -85.4% a year. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Odyssey Group International profitable?+

Odyssey Group International reported about -$6 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How fast is Odyssey Group International growing?+

Odyssey Group International's revenue has compounded at roughly -85.4% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside ODYY's margins and free cash flow. This is analysis from SEC filings, not investment advice.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 27 Oct 2026, covering the period ending 31 Jul 2026, as reported to the SEC. Data last refreshed 29 Oct 2026. How this is calculated.

Fiscal year ends Jul.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with ODYY

CompareIntrinsic value
NVNOEnVVeno Medical Corporation
$7.00-2.43%10
RDGLVivos Inc.
$0.04-1.64%40
PAVMPAVmed Inc.
$1.66-8.79%25
MBOTMicrobot Medical Inc.
$1.14+4.59%25
SIGYSigyn Therapeutics Inc.
$0.03+0.00%30
GCTKGlucotrack Inc.
$0.40-12.66%25
FOFAFamily Office of America Inc.
$0.78+0.00%16
YBGJYubo International Biotech Limited
$0.01+0.00%0

Spot a number that looks wrong? Check it in ODYY's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ODYY

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.